Skip to content
Screener

Harrow HROW Common Stock

Common Stock at other companies

AbbVie logo
AbbVieABBV
$18M0.0%
Eton Pharmaceuticals, Inc. logo
Eton Pharmaceuticals, Inc.ETON
$27K0.0%
Bausch + Lomb logo
Bausch + LombBLCO
$0
Ocular Therapeutix logo
Ocular TherapeutixOCUL
$22K+37.5%
Opko Health logo
Opko HealthOPK
$7.76M-4.1%
Bausch Health Companies logo
Bausch Health CompaniesBHC
$10.54B+0.3%

Other financials

Income statement

See full
Revenue$44.2M-7.6%
Gross profit$27.0M-16.3%
Operating income-$22.1M-96.6%
Net income-$27.6M-55.2%
EPS (diluted)-$0.74-48.0%

Balance sheet

See full
Cash & equivalents$94.6M+41.8%
Total debt$308.6M-32.9%
Total equity$28.7M-49.1%
Total assets$419.5M+15.2%

Cash flow

See full
Operating cash flow-$9.0M-146%
CapEx$194.0K+14.1%
Free cash flow-$9.2M-147%

Valuation

See full
Market cap$1.49B+22.8%
Enterprise value$1.7B+5.6%
P/S5.5×+0.2×

Profitability

See full
Gross margin74.1%-0.4pp
Operating margin7.3%+5.2pp
Net margin-19.8%+18.0pp
FCF margin5.7%+5.0pp

Returns & leverage

See full
Return on equity-50%+17.5pp
Debt / equity10.7×+2.6×
Current ratio2.5×+1.6×

Where this comes from

Reported directly by Harrow in its filing.

Tagged under the XBRL concept us-gaap:CommonStockSharesAuthorized.

The source filing: Harrow’s 10-Q, filed May 11, 2026.

Filed
May 11, 2026, 4:31 PM EDT
Fiscal quarter
Q1 FY2026
Calendar quarter
Q1 2026
Accession
0001493152-26-022254
Line itemMarch 31, 2026December 31, 2025
TOTAL LIABILITIES391,192,000347,391,000
Commitments and contingencies
STOCKHOLDERS’ EQUITY
Common stock, $0.001 par value, 50,000,000 shares authorized, 37,269,400 and 37,229,159 shares issued and outstanding at March 31, 2026 and December 31, 2025, respectively37,00037,000
Additional paid-in capital212,795,000208,933,000
Accumulated deficit(184,126,000)(156,524,000)
TOTAL HARROW, INC. STOCKHOLDERS’ EQUITY28,706,00052,446,000
Noncontrolling interests(355,000)(355,000)

Item 1. Financial Statements (unaudited) Item

FAQ

What is Harrow's common stock?
Harrow (HROW) reported common stock of 50M in Q1 2026.
How has Harrow's common stock changed year-over-year?
Harrow's common stock decreased by 0.0% year-over-year, from 50M to 50M.
What is the long-term trend for Harrow's common stock?
Over 5 years (2020 to 2025), Harrow's common stock has grown at a 0.0% compound annual growth rate (CAGR), from 50M to 50M.
What does common stock mean?
The par value of all common shares issued and outstanding, typically a nominal amount ($0.01 or $0.001 per share).

Ask your AI about Harrow's common stock.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude